Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A study of referral bias in NMOSD and MOGAD cohorts.
Leal Rato M, Chen B, Francis A, Messina S, Miron M, Sharawakanda Y, O'Sullivan E, Cooper S, Fisniku L, Halfpenny C, Martin R, Hobart J, Rashid W, Hemingway C, Williams V, Hacohen Y, Dobson R, Ramdas S, Leite MI, Palace J, Geraldes R. Leal Rato M, et al. Among authors: dobson r. Mult Scler Relat Disord. 2024 May;85:105553. doi: 10.1016/j.msard.2024.105553. Epub 2024 Mar 14. Mult Scler Relat Disord. 2024. PMID: 38552551 Free article.
Visibility and representation of women in multiple sclerosis research.
Thomson A, Horne R, Chung C, Marta M, Giovannoni G, Palace J, Dobson R. Thomson A, et al. Among authors: dobson r. Neurology. 2019 Apr 9;92(15):713-719. doi: 10.1212/WNL.0000000000007276. Epub 2019 Mar 20. Neurology. 2019. PMID: 30894447 Free PMC article. Review.
Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis.
Allen-Philbey K, Stennett A, Begum T, Johnson AC, Dobson R, Giovannoni G, Gnanapavan S, Marta M, Smets I, Turner BP, Baker D, Mathews J, Schmierer K. Allen-Philbey K, et al. Among authors: dobson r. Mult Scler Relat Disord. 2021 Jul;52:103028. doi: 10.1016/j.msard.2021.103028. Epub 2021 May 18. Mult Scler Relat Disord. 2021. PMID: 34049216 Free PMC article.
Evaluation of remote assessments for multiple sclerosis in an in-home setting.
Kuri A, Jacobs BM, Leddy S, Schmierer K, Turner B, Allen-Philbey K, Stennett A, Giovannoni G, Thomson A, Dobson R. Kuri A, et al. Among authors: dobson r. Mult Scler Relat Disord. 2021 Sep;54:103125. doi: 10.1016/j.msard.2021.103125. Epub 2021 Jun 29. Mult Scler Relat Disord. 2021. PMID: 34246018
Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders.
Camera V, Messina S, Elhadd KT, Sanpera-Iglesias J, Mariano R, Hacohen Y, Dobson R, Meletti S, Wassmer E, Lim MJ, Huda S, Hemingway C, Leite MI, Ramdas S, Palace J. Camera V, et al. Among authors: dobson r. J Neurol Neurosurg Psychiatry. 2022 Jan;93(1):101-111. doi: 10.1136/jnnp-2021-327206. Epub 2021 Sep 28. J Neurol Neurosurg Psychiatry. 2022. PMID: 34583946
OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis.
Dobson R, Craner M, Waddingham E, Miller A, Cavey A, Webb S, Hemingway C, Hobart J, Evangelou N, Scolding N, Rog D, Nicholas R, Marta M, Blain C, Young CA, Ford HL, Matthews PM. Dobson R, et al. BMJ Open. 2021 Nov 25;11(11):e050176. doi: 10.1136/bmjopen-2021-050176. BMJ Open. 2021. PMID: 34824113 Free PMC article.
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021.
Tur C, Dubessy AL, Otero-Romero S, Amato MP, Derfuss T, Di Pauli F, Iacobaeus E, Mycko M, Abboud H, Achiron A, Bellinvia A, Boyko A, Casanova JL, Clifford D, Dobson R, Farez MF, Filippi M, Fitzgerald KC, Fonderico M, Gouider R, Hacohen Y, Hellwig K, Hemmer B, Kappos L, Ladeira F, Lebrun-Frénay C, Louapre C, Magyari M, Mehling M, Oreja-Guevara C, Pandit L, Papeix C, Piehl F, Portaccio E, Ruiz-Camps I, Selmaj K, Simpson-Yap S, Siva A, Sorensen PS, Sormani MP, Trojano M, Vaknin-Dembinsky A, Vukusic S, Weinshenker B, Wiendl H, Winkelmann A, Zuluaga Rodas MI, Tintoré M, Stankoff B. Tur C, et al. Among authors: dobson r. Mult Scler. 2022 Aug;28(9):1424-1456. doi: 10.1177/13524585211069068. Epub 2022 Feb 23. Mult Scler. 2022. PMID: 35196927 Review.
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS).
Dobson R, Craner M, Waddingham E, Miller A, Pindoria J, Cavey A, Blain C, De Luca G, Evangelou N, Ford H, Gallagher P, George K, Geraldes Ramos Dias R, Harman P, Hobart J, King T, Linighan R, MacDougall N, Marta M, Mitchell S, Nicholas R, Rog D, Scalfari A, Scolding N, Webb S, White S, Wilton J, Young C, Matthews PM. Dobson R, et al. Mult Scler Relat Disord. 2022 Jul;63:103894. doi: 10.1016/j.msard.2022.103894. Epub 2022 May 20. Mult Scler Relat Disord. 2022. PMID: 35636271 Free article.
Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis.
Allen-Philbey K, Stennett A, Begum T, Johnson AC, MacDougall A, Green S, Dobson R, Giovannoni G, Gnanapavan S, Marta M, Smets I, Turner BP, Baker D, Mathews J, Schmierer K. Allen-Philbey K, et al. Among authors: dobson r. Mult Scler Relat Disord. 2022 Sep;65:104022. doi: 10.1016/j.msard.2022.104022. Epub 2022 Jul 3. Mult Scler Relat Disord. 2022. PMID: 35816953 Free PMC article.
1,284 results